221. Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline.
作者: Hau Liu.;Neil M Paige.;Caroline L Goldzweig.;Elaine Wong.;Annie Zhou.;Marika J Suttorp.;Brett Munjas.;Eric Orwoll.;Paul Shekelle.
来源: Ann Intern Med. 2008年148卷9期685-701页
Screening for low bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA) is the primary way to identify asymptomatic men who might benefit from osteoporosis treatment. Identifying men at risk for low BMD and fracture can help clinicians determine which men should be tested.
222. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
作者: Ellen Warner.;Hans Messersmith.;Petrina Causer.;Andrea Eisen.;Rene Shumak.;Donald Plewes.
来源: Ann Intern Med. 2008年148卷9期671-9页
A sensitive and acceptable screening regimen for women at high risk for breast cancer is essential. Contrast-enhanced magnetic resonance imaging (MRI) of the breast is highly sensitive for diagnosis of breast cancer but has variable specificity.
223. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections.
作者: Matthew T James.;Joslyn Conley.;Marcello Tonelli.;Braden J Manns.;Jennifer MacRae.;Brenda R Hemmelgarn.; .
来源: Ann Intern Med. 2008年148卷8期596-605页
Catheter-related infections cause morbidity and mortality in patients undergoing hemodialysis.
224. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.
作者: Parminder Raina.;Pasqualina Santaguida.;Afisi Ismaila.;Christopher Patterson.;David Cowan.;Mitchell Levine.;Lynda Booker.;Mark Oremus.
来源: Ann Intern Med. 2008年148卷5期379-97页
The effectiveness of the 5 U.S. Food and Drug Administration-approved pharmacologic therapies for dementias in achieving clinically relevant improvements is unclear.
225. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
作者: Aine M Kelly.;Ben Dwamena.;Paul Cronin.;Steven J Bernstein.;Ruth C Carlos.
来源: Ann Intern Med. 2008年148卷4期284-94页
N-Acetylcysteine, theophylline, and other agents have shown inconsistent results in reducing contrast-induced nephropathy.
226. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force.
作者: Peggy Nygren.;Rongwei Fu.;Michele Freeman.;Christina Bougatsos.;Mark Klebanoff.;Jeanne-Marie Guise.; .
来源: Ann Intern Med. 2008年148卷3期220-33页
Bacterial vaginosis is the most common lower genital tract syndrome among women of reproductive age. There has been continued debate about the value of screening and treating asymptomatic pregnant women for bacterial vaginosis.
227. Systematic review: comparing routine and selective invasive strategies for the acute coronary syndrome.
作者: Rehan Qayyum.;M Rizwan Khalid.;Jurga Adomaityte.;Stylianos P Papadakos.;Frank C Messineo.
来源: Ann Intern Med. 2008年148卷3期186-96页
Patients with non-ST-segment elevation acute coronary syndrome (ACS) are managed with either a routine invasive strategy, in which all patients receive coronary angiography, or a selective invasive strategy, in which only patients with refractory or inducible ischemia receive coronary angiography.
228. Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement.
Update of the 1996 U.S. Preventive Services Task Force statement about screening for asymptomatic carotid artery stenosis (CAS) in the general population.
229. Meta-analysis: vitamin D compounds in chronic kidney disease.
作者: Suetonia C Palmer.;David O McGregor.;Petra Macaskill.;Jonathan C Craig.;Grahame J Elder.;Giovanni F M Strippoli.
来源: Ann Intern Med. 2007年147卷12期840-53页
Vitamin D compounds are widely used to prevent and treat secondary hyperparathyroidism.
230. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.
作者: Catherine MacLean.;Sydne Newberry.;Margaret Maglione.;Maureen McMahon.;Veena Ranganath.;Marika Suttorp.;Walter Mojica.;Martha Timmer.;Alicia Alexander.;Melissa McNamara.;Sheetal B Desai.;Annie Zhou.;Susan Chen.;Jason Carter.;Carlo Tringale.;Di Valentine.;Breanne Johnsen.;Jennifer Grossman.
来源: Ann Intern Med. 2008年148卷3期197-213页
Although several agents are available to treat osteoporosis, the relative efficacy and toxicity of these agents when used to prevent fractures has not been well described.
231. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.
作者: David B Matchar.;Douglas C McCrory.;Lori A Orlando.;Manesh R Patel.;Uptal D Patel.;Meenal B Patwardhan.;Benjamin Powers.;Gregory P Samsa.;Rebecca N Gray.
来源: Ann Intern Med. 2008年148卷1期16-29页
The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown.
232. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.
作者: Regina Kunz.;Chris Friedrich.;Marcel Wolbers.;Johannes F E Mann.
来源: Ann Intern Med. 2008年148卷1期30-48页
Reduction of proteinuria is associated with delayed progression of chronic kidney disease. Reports suggest that angiotensin-receptor blockers (ARBs) reduce proteinuria, but results are variable. The relative effect of ARBs and angiotensin-converting enzyme (ACE) inhibitors, and their combined administration, remains uncertain.
233. Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication.
作者: Lorenzo Fuccio.;Maria Eugenia Minardi.;Rocco Maurizio Zagari.;Diego Grilli.;Nicola Magrini.;Franco Bazzoli.
来源: Ann Intern Med. 2007年147卷8期553-62页
Proton-pump inhibitor (PPI)-based triple therapy is the recommended first-line treatment for Helicobacter pylori infection. A consensus on treatment duration is lacking.
234. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery.
作者: Dena M Bravata.;Allison L Gienger.;Kathryn M McDonald.;Vandana Sundaram.;Marco V Perez.;Robin Varghese.;John R Kapoor.;Reza Ardehali.;Douglas K Owens.;Mark A Hlatky.
来源: Ann Intern Med. 2007年147卷10期703-16页
The comparative effectiveness of coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) for patients in whom both procedures are feasible remains poorly understood.
235. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline.
Medications are the most frequently prescribed therapy for low back pain. A challenge in choosing pharmacologic therapy is that each class of medication is associated with a unique balance of risks and benefits.
236. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline.
Many nonpharmacologic therapies are available for treatment of low back pain.
237. Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection.
作者: Lillian Sung.;Paul C Nathan.;Shabbir M H Alibhai.;George A Tomlinson.;Joseph Beyene.
来源: Ann Intern Med. 2007年147卷6期400-11页
Benefits of prophylactic hematopoietic colony-stimulating factors (CSFs) in adults and children receiving cancer chemotherapy or undergoing stem-cell transplantation (SCT) are unclear.
238. Meta-analysis: the effect of dietary counseling for weight loss.
作者: Michael L Dansinger.;Athina Tatsioni.;John B Wong.;Mei Chung.;Ethan M Balk.
来源: Ann Intern Med. 2007年147卷1期41-50页
Dietary and lifestyle modification efforts are the primary treatments for people who are obese or overweight. The effect of dietary counseling on long-term weight change is unclear.
240. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.
Atrial fibrillation is a strong independent risk factor for stroke.
|